healthcare - PitchBook

Healthcare

More news about this topic

Medtech Quarterly

Medtech Report: MiRus Lifts VC Funding in Q2

July 31, 2026

The Q2 2026 Medtech Report report provides an analysis of recent VC and PE activity and includes a market map of leading VC- and PE-backed companies in the space.

Research

Learn more »
Healthtech Quarterly

Healthtech Report: Commure’s $7 Billion Raise Headlines a Slow Quarter

July 27, 2026

The Q2 2026 Healthtech Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.

Research

Learn more »
Biopharma Quarterly

Biopharma Report: Funding Tops $10 Billion with Record Exits

July 24, 2026

The Q2 2026 Biopharma Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.

Research

Learn more »
Healthcare Services Public Comp Sheet

Healthcare Services Public Comp Sheet: Robust Q2 Rebound After Being Left for Dead

July 15, 2026

Our Healthcare Services Public Comp Sheet tracks stock performances, valuations, and market caps of key publicly traded healthcare services companies.

Research

Learn more »
Commentary

Parabilis now the largest VC-backed biotech IPO

June 10, 2026

The stock jumped 58% in its first day of trading on the Nasdaq Global Select Market on Wednesday.

Article

Learn more »
Pharma Biotools Quarterly

Pharma Biotools VC Trends

June 3, 2026

The Q1 2026 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Venture Capital

Some investors are turning to biotech as a hedge against potential AI bubbles

May 29, 2026

They’re betting that with the continuous need for health care, the sector is more immune.

Article

Learn more »
Medtech Quarterly

Medtech VC and PE Trends

May 13, 2026

The Q1 2026 Medtech VC and PE Trends report provides an analysis of recent VC and PE activity and includes a market map of leading VC- and PE-backed companies in the space.

Research

Learn more »
Healthcare

Elder care is rare bright spot in tough Q1 for healthcare services

May 7, 2026

Deal value fell more than 23% YoY as buyers became more discriminating.

Article

Learn more »
Healthcare Services Report

Healthcare Services Report

May 7, 2026

The Q1 2026 Healthcare Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.

Research

Learn more »
Healthtech Quarterly

Healthtech VC Trends

April 30, 2026

The Q1 2026 Healthtech VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
AI

PitchBook Analyst Note: AI Will Deliver Care to Billions and Break the System That Built It

April 29, 2026

81% of US physicians now use AI. We map a five-layer AI care delivery stack, profile dozens of companies, and project healthcare cost scenarios.

Research

Learn more »
Biopharma Quarterly

Biopharma VC Trends

April 28, 2026

Biopharma VC deal value fell to $7.2 billion in Q1 2026 as capital shifted toward exits. We examine modality trends, oncology, and obesity deal flow, and what a strengthening exit environment means for 2026.

Research

Learn more »
Leveraged Loans

Europe’s leveraged loan borrowers shrink 2028 maturity wall, but challenges loom

April 28, 2026

A sizeable portion of debt remains from the buyout boom of 2021.

Article

Learn more »
Medtech Public Comp Sheet

Medtech Public Comp Sheet and Valuation Guide

April 24, 2026

Our Medtech Public Comp Sheet and Valuation Guide tracks stock performances, valuations, and market caps of key publicly traded medtech companies.

Research

Learn more »
Healthtech Public Comp Sheet

Healthtech Public Comp Sheet and Valuation Guide

April 15, 2026

Our Healthtech Public Comp Sheet and Valuation Guide tracks stock performances, valuations, and market caps of key publicly traded healthtech companies.

Research

Learn more »
Biopharma

Jeito holds $1.2B close for biopharma fund as industry braces for next patent cliff

April 8, 2026

Investors are eyeing a strong M&A cycle ahead of 2030.

Article

Learn more »
Healthcare Funds Report

Healthcare Funds Report

April 2, 2026

The H2 2025 Healthcare Funds Report offers a comprehensive guide to healthcare and life sciences specialist managers across both private equity and venture capital.

Research

Learn more »